Overview of The Nicotinic (alpha4beta2)2alpha4 Receptor as A Potential Drug Target

Target Name: Nicotinic (alpha4beta2)2alpha4 receptor

NCBI ID: P32844

Nicotinic (alpha4beta2)2alpha4 receptor

Other Name(s): nAChR Nicotinic (alpha4beta2)2alpha4

Overview of The Nicotinic (alpha4beta2)2alpha4 Receptor as A Potential Drug Target

The Nicotinic (alpha4beta2)2alpha4 receptor (nAChR) is a G protein-coupled receptor that plays a crucial role in various physiological processes in the body. It is a member of the nicotinic acetylcholine receptor subfamily and is found primarily in the central nervous system ( CNS) and peripheral tissues. The nAChR is involved in the regulation of neural transmission, muscle contractions, and blood pressure, among other functions.

Recent studies have identified the nAChR as a potential drug target in the treatment of various neurological and psychiatric disorders. Its function in modulating neural activity has led to the exploration of new therapeutic approaches that target this receptor. In this article, we will provide an overview of the nAChR, its structure, function, and potential as a drug target.

Structure and Function

The nAChR is a transmembrane protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The transmembrane region is responsible for the delivery and retention of the receptor in the cell membrane, while the intracellular domain is involved in the formation of the receptor complex with other proteins.

The nAChR has a unique 尾2 subunit that is responsible for the nicotinic acetylcholine receptor interaction. This subunit consists of a long N-terminal region, a transmembrane region, and a C-terminal region. The 尾2 subunit has a unique feature, known as the \"伪\" region, which is involved in the formation of the nicotinic acetylcholine receptor complex.

The nAChR is involved in the regulation of various physiological processes, including neuronal activity, muscle contractions, and blood pressure. It has been shown to play a role in the modulation of neural transmission, specifically in the regulation of action potential generation and propagation. nAChR has also been shown to modulate muscle contractions, such as in the regulation of muscle fibers excitability and muscle force production.

In addition to its role in neural and muscle function, the nAChR is also involved in the regulation of blood pressure. Studies have shown that the nAChR has a negative effect on blood pressure and is a potential target for hypertension treatment.

Drug Target Potential

The nAChR is a potential drug target due to its involvement in various physiological processes. Its unique 尾2 subunit and 伪 region have been identified as potential drug targets.

One approach to targeting the nAChR is through the use of small molecules that can modulate the activity of the receptor. Currently, several compounds have been shown to interact with the nAChR and modulate its activity. These compounds include benzodiazepines, which are known to modulate the activity of GABA receptors, as well as A尾42, which is a neurotoxin that has been shown to modulate the activity of the nAChR.

Another approach to targeting the nAChR is through the use of monoclonal antibodies (MCAs). MCAs are laboratory-produced antibodies that can selectively bind to a specific protein. Studies have shown that MCA can be used to block the nAChR and modulate its activity.

In conclusion, the nAChR is a G protein-coupled receptor that plays a crucial role in various physiological processes in the body. Its unique 尾2 subunit and 伪 region have been identified as potential drug targets. Currently, several compounds and MCA have been shown to interact with the nAChR and modulate its activity. Further studies are needed to fully understand the potential of the nAChR as a drug target and to develop safe and effective treatments.

Protein Name: Nicotinic (alpha4beta2)2alpha4 Receptor

The "Nicotinic (alpha4beta2)2alpha4 receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Nicotinic (alpha4beta2)2alpha4 receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets